Cargando…

The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19

INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlact...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshammary, Amal F., AlQarni, Hassan M., Farzan, Raed, Ali Khan, Imran, Vennu, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265175/
https://www.ncbi.nlm.nih.gov/pubmed/37144596
http://dx.doi.org/10.1111/crj.13628
_version_ 1785058478289584128
author Alshammary, Amal F.
AlQarni, Hassan M.
Farzan, Raed
Ali Khan, Imran
Vennu, Vishal
author_facet Alshammary, Amal F.
AlQarni, Hassan M.
Farzan, Raed
Ali Khan, Imran
Vennu, Vishal
author_sort Alshammary, Amal F.
collection PubMed
description INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlactatemia with mortality among critically ill Covid‐19 patients admitted to the intensive care unit (ICU). METHODS: In this single‐centre retrospective study, we included 171 patients aged ≥18 years with confirmed Covid‐19 admitted to the ICU at a tertiary healthcare clinic in the Eastern region of Saudi Arabia between 1 March 2020 and 31 January 2021. Patients were divided into two groups: survivor and non‐survivor. The survivors have been identified as the patients discharged from the ICU alive. The VTE risk was defined using a Padua prediction score (PPS) >4. The blood lactate concentration (BLC) cut‐off value >2 mmol/L was used to determine the blood hyperlactatemia. RESULTS: Multi‐factor Cox analysis showed that PPS >4 and BLC >2 mmol/L were more likely to be significantly associated with higher odds of ICU mortality in critically ill Covid‐19 patients (hazard ratio [HR] = 2.80, 95% confidence interval [CI] = 1.00–8.08, p = 0.050; HR = 3.87, 95% CI = 1.12–13.45, p = 0.033, respectively). The Area under the Curve for VTE and blood hyperlactatemia were 0.62 and 0.85, respectively. CONCLUSION: VTE risk and blood hyperlactatemia have been associated with a higher mortality risk in critically ill Covid‐19 patients who are hospitalized in the ICU in Saudi Arabia. According to our findings, these people needed more effective VTE prevention strategies based on a personalized assessment of their risk of bleeding. Moreover, persons without diabetes and other groups with a high risk of dying from COVID‐19 may be recognized by measuring glucose as having elevated glucose and lactate jointly.
format Online
Article
Text
id pubmed-10265175
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102651752023-06-15 The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 Alshammary, Amal F. AlQarni, Hassan M. Farzan, Raed Ali Khan, Imran Vennu, Vishal Clin Respir J Original Articles INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlactatemia with mortality among critically ill Covid‐19 patients admitted to the intensive care unit (ICU). METHODS: In this single‐centre retrospective study, we included 171 patients aged ≥18 years with confirmed Covid‐19 admitted to the ICU at a tertiary healthcare clinic in the Eastern region of Saudi Arabia between 1 March 2020 and 31 January 2021. Patients were divided into two groups: survivor and non‐survivor. The survivors have been identified as the patients discharged from the ICU alive. The VTE risk was defined using a Padua prediction score (PPS) >4. The blood lactate concentration (BLC) cut‐off value >2 mmol/L was used to determine the blood hyperlactatemia. RESULTS: Multi‐factor Cox analysis showed that PPS >4 and BLC >2 mmol/L were more likely to be significantly associated with higher odds of ICU mortality in critically ill Covid‐19 patients (hazard ratio [HR] = 2.80, 95% confidence interval [CI] = 1.00–8.08, p = 0.050; HR = 3.87, 95% CI = 1.12–13.45, p = 0.033, respectively). The Area under the Curve for VTE and blood hyperlactatemia were 0.62 and 0.85, respectively. CONCLUSION: VTE risk and blood hyperlactatemia have been associated with a higher mortality risk in critically ill Covid‐19 patients who are hospitalized in the ICU in Saudi Arabia. According to our findings, these people needed more effective VTE prevention strategies based on a personalized assessment of their risk of bleeding. Moreover, persons without diabetes and other groups with a high risk of dying from COVID‐19 may be recognized by measuring glucose as having elevated glucose and lactate jointly. John Wiley and Sons Inc. 2023-05-05 /pmc/articles/PMC10265175/ /pubmed/37144596 http://dx.doi.org/10.1111/crj.13628 Text en © 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Alshammary, Amal F.
AlQarni, Hassan M.
Farzan, Raed
Ali Khan, Imran
Vennu, Vishal
The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title_full The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title_fullStr The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title_full_unstemmed The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title_short The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
title_sort risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with covid‐19
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265175/
https://www.ncbi.nlm.nih.gov/pubmed/37144596
http://dx.doi.org/10.1111/crj.13628
work_keys_str_mv AT alshammaryamalf theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT alqarnihassanm theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT farzanraed theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT alikhanimran theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT vennuvishal theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT alshammaryamalf riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT alqarnihassanm riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT farzanraed riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT alikhanimran riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19
AT vennuvishal riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19